Flying The Web For News.
  • 2024 Presidential Election
    2024 Presidential Election
  • Career Exam Study
    Career Exam Study
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News
+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service

Press Release: Patient Enrollment Commenced in Pivotal Phase 3 Trial of Rexlemestrocel-L for Chronic Low Back Pain

Details
Category: Globe NewsWire News Distribution Service

NEW YORK, July 21, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced today that the confirmatory Phase 3 trial of its allogeneic, immunoselected, and industrially manufactured stromal cell product rexlemestrocel-L in patients with chronic low back pain (CLBP) due to inflammatory degenerative disc disease of…


Posted: 2024-07-22 00:45:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.

Tags

press | release | patient | enrollment | commenced


Related News Stories From The Web And More

Related Bing News Search Results

Press Release: Patient Enrollment Commenced in Pivotal Phase 3 Trial of Rexlemestrocel-L for Chronic Low Back Pain - Newscast

Satellos Reports Q3 2024 Financial Results and Provides Clinical Update

Wed, 13 Nov 2024 03:59:00 GMT All references to currency in this press release ... enrollment in the healthy volunteer single-ascending-dose arm by year end, complete enrollment in the multiple-ascending-dose healthy volunteer arm ...

Grace Therapeutics Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update

Wed, 13 Nov 2024 00:00:00 GMT Highlights for Second Fiscal Quarter 2025 and Recent Weeks Announced completion of patient enrollment in the Phase 3 STRIVE-ON ... Statements in this press release that are not statements of ...

Medical Technology Stocks and First Patient Enrollment Milestones

Tue, 12 Nov 2024 06:17:00 GMT "By 2024, the market is projected to reach a staggering US$597.00bn worldwide. Among these markets, Medical Devices are expected to dominate, with a projected market volume of US$508.00bn by 2024.

Palisade Bio Reports Third Quarter 2024 Financial Results and Outlines Key Accomplishments and Next Steps to Advance Lead Program PALI-2108

Mon, 11 Nov 2024 23:45:00 GMT Commenced enrollment and dosing in Phase 1 clinical study ... The initiation of our Phase 1 clinical trial and patient enrollment and dosing are important milestones in our clinical program,” ...

Open enrollment for Health Insurance Marketplace plans has started. How long it lasts

Mon, 11 Nov 2024 15:14:00 GMT Open enrollment for health care through the Health Insurance Marketplace on HealthCare.gov has begun. It runs through Jan. 15, 2025.


Blow Us A Whistle